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ABSTRACT 
When gametes or embryos are not available or cannot be successfully cryopreserved, 
somatic cells should be considered for cryobanking of material from endangered fish 
species. Although the preservation of such material is not difficult, their collection 
and ultimate cryopreservation can present logistic difficulties; and initial storage is 
probably needed to retain viability before cryopreservation. The aim of this study was 
to develop a reliable method for initial storage and cryoprotectant treatment of liver 
cells that could be employed prior to the cryopreservation. Two bathing solutions 
were assessed for initial storage at 4°C or 6°C over a 48 hour storage period in chilling 
sensitivity studies. Medium C (lml L~15 supplemented with Hepes (5.958g1L), 
NaHC03 (0.42g/L), Gentamycine (lOOmglL), Amphotericine B (2.5mgIL), L-
glutamine (0.374g/L) and Fetal bovine serum (10%)) and PBS were used as bathing 
solutions of the cells stored at 4°C or 6°C for up to 48 hours. Fluorescein diacetate ­
propidium iodide staining was used to assess the viability after 12,24 and 48 hours of 
storage. Four cryoprotectants (CPAs) were investigated at different concentrations-
DMSO (lM), MeOH (2M, 3M and 4M), PG (lM) and sucrose (0.05M and O.IM)­
and used to treat the cells for up to 30 minutes. Viability assessment was done using 
Trypan blue and Fluorescein diacetate - propidium iodide staining after 10, 20 or 30 
minute exposure to CP As. Fresh and stored liver cells were frozen using slow cooling 
methods based on existing LIRANS procedures for cryopreservation of zebrafish 
blastomeres. The results indicated that exposure to 4·C PBS for 12, hours was an 
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optimal condition for storage of liver cell prior to cryopreservation. In addition, 
results showed that cryopreservation at a slow freezing rate following 10 minute 
treatment of 2M methanol, allowed the recovery of more than 50% of the zebrafish 
liver cells. 
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CHAPTER 1 INTRODUCTION 
1.1 Aim of the researc:l an(~ ".g,nificance 
Cryobanking is established to retain collections of the genetic diversity from 
various species. DNA, protein components and viable cell andior tissues of animal 
species are conserved long term as frozen, freeze-dried and dried collections. Although 
cryobanking seeks to hold samples of a wide range of species, there is a strong focus on 
threatened and endangered species, especially by the destruction of habitats. Whilst 
cryopreservation of fish eggs or embryos has yet to be achieved, banking of cultures of 
somatic cells from explants of tissue or post-mortem tissue isolates taken from sacrificed 
fish would be an alternative approach. The aim of the present work was to develop 
protocols for the short-term storage of tissue explants from fish, preceding 
cryopreservation. This will bring significant advantages to overcome the difficulty in 
obtaining and maintaining such materials especially from endangered species. 
The successful cryopreservation of viable tissue explants would provide valuable 
procedures for use by third parties in subsequent cell culture and cryo-banking. This 
allows initial storage of tissue explants, which can be subsequently be resuscitated and 
used to establish cell cultures for cryo-banking. However, obtaining materials is difficult, 
particularly when materials require transfer or retention for a period of time before 
cryopreservation. Hence there is the need for an initial storage method maintaining 
viability prior to cryopreservation. The approach to adopt will be to use post-mortem 
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material from a model freshwater species, zebrafish (Danio rerio) , maintained under 
laboratory conditions. Liver cells are used as a model tissue in this investigation. 
There were three distinct phases to the study: 
(1) Cryoprotectant selection for use with both fresh and stored cells. The toxicity of a 
range of cryoprotectants (CP As) and CPA mixtures were optimised using vital 
staining assessment. 
(2) Determination 	 of an initial, pre-cryopreservation, storage regime. Two 
temperatures (4 and 6°C) and bathing solutions (medium C and PBS) were 
investigated to determine whether they could be used for short term storage, prior 
to successful cryopreservation for long term storage of viable cells in liquid 
nitrogen. 
(3) Comparing cryopreservation of fresh and stored cells. Promising tissue explants 
and CPA treatments were assessed for cryopreservation by slow cooling. Post 
preservation survival was assessed using vital staining. 
1.2 Principles of cryobiology 
The viability of cells and tissues is usually reduced when exposure to low 
temperatures. However, cells, tissues and organisms can be maintained for long periods if 
cryopreserved, as biochemical reactions are suspended at extremely low temperatures. 
Whilst the exposure of living cells to low temperatures results in varied and contradictory 
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outcomes, there are fundamental mechanisms determining the reactions of biological 
systems to low temperature and solidification of liquid water. 
There are two damaging events that occur when cells and tissues are exposed to 
low temperatures, chilling injury and freezing damage. 
:".2.1 Chilling injury 
At temperatures close to or just below ooe without freezing, many types of cells 
and tissues are damaged or even killed. The term "chilling injury" was initially used in 
the early eighteenth century to explain the observable fact that plants were damaged 
permanently when experiencing low temperatures above the freezing point of water 
(Levitt, 1980). "Temperature shock:' was claimed to be the cause of irretrievable damage 
of mammalian sperm due to rapid cooling below body temperature (Watson and Morris, 
1987). However, both temperature shock and chilling injury are thought to be caused by 
related mechanisms. To describe both occurrences, the tenn "cold shocle' is used, which 
describes the damaging effect of reduction of temperature and that the degree of damage 
is dependant on cooling rate (Watson and Morris, 1987). "Indirect chilling injury" is 
another term for chilling i~ury and is used to describe a phenomenon, which is unrelated 
to the rate of cooling, that is exhibited after long term exposure to low temperature 
(Watson and Morris, 1987). 
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1.2.1.1 	 Cold shock 
The fundamental characteristics of cold shock are described as follows (Morris, 
1987): 
(a) during rapid cooling to 	a sufficiently low temperature, all cell types may be 
considered sensitive to cold shock; 
(b) the rate 	of cooling affects cellular viability with more injury following "rapid" 
rather than "slow: cooling; 
(c) cold shock injury is almost independent of the rate of warming, in cases where 
this does not significantly increase the length of exposure to low temperature; 
(d) injury 	 is increased as the period of isothermal incubation at the reduced 
temperature is extended; 
(e) 	loss of membrane permeability occurs following rapid cooling, and in some 
instances, may be reversed upon rewarming; 
(f) 	the culture condition before cooling and the addition of specific compounds 
(CPA) may alter the response of cells. 
In animal cells, chilling injury is mainly due to phase transitions in cell 
membranes (Hays, L.M., et aI., 2001). In freeze-fracture studies, morphological changes 
to membranes related to lipid phase transition were caused by temperature change from 
30 to 5°C in sperm of sheep (Holt and North, 1984). Lipid phase transition in the cell 
membrane was studied by use of Fourier transformation infrared spectroscopy (FTIR) in 
which sperm (Meyers, 2005; Riker et al., 2006), bovine oocytes (Arav et aI., 1996), 
human oocyte and zygotes (Ghetler et ai, 2005), pig platelets (Walkers et ai, 2003), 
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human platelets (Crowe et aI., 1999; Gousset et al, 2002; Tablin et ai, 2000 and 
Tsvetkova et aI, 2000) and hrunan erythrocytes (walkers, 2002). 
1.2.1.2 Indirect chilling injury 
Indirect chilling injury is independent of the cooling rate and usually manifests 
after a period of exposure to lower temperatures. However, indirect chilling injury may 
be apparent within minutes in certain tissues such as mammalian oocytes or embryos and 
some stages of insect embryos (Leiba et aI., 1996, Mazur et aI., 1992). 
A progression of occurrences may take place in the cellular membrane in response 
to a decrease in temperature (Fig. 1.1). An increase in membrane viscosity is the initial 
consequence of a fall in temperature, and phase separation may occur depending on the 
type of cells and the extent of the reduction in temperature (Cossins, 1983). Membrane 
function will be affected by both incidents. Although many cell types can balance phase 
change by modifying the lipid compensation of their membranes, these equalizations are 
not usually perfect. Cells are frequently trapped in a state of permanent phase change or 
transition when the period of exposure to low temperatures is extended. The alteration of 
the activities of membrane proteins and membrane-associated enzymes is induced when 
many biological properties of the membrane are altered following phase transition 
(Cossins, 1983). 
Fig. 1.1 Flow diagram of membrane events during a reduction in temperature, indicating potential long-term 
responses (from Morris and Clark, 1987) 
Reduction in Reduction in Reduction in 
temperature Increase in temperature Phase temperature Phase 
--------------7 membrane viscosity ---------------7 Separation --------------7 Separation 
1/ 
 I 
Alteration in lipid Insufficient 
composition to reverse / modification in lipid phase behaviour Composition/ 
Decreased Long-term phase 
viscosity seperation1 
Nucleation within 
the membrane 
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Low temperatures may affect the structure and function of proteins by decreasing 
the rate of enzyme activity and possibly the denaturation of proteins (Jaenicke, 1981). 
Changes in enzyme activity can result in the uncoupling of metabolic pathways. The 
structure of the cytoskeleton may also be affected by reduced temperature, such as low 
temperature depolymerisation of microtubules (Behnke and Forer, 1967; Weber et aI., 
1975; Magistrini and Szollosi, 1980), which triggers the irreversible disruption of cellular 
processes such as cell division in oocytes (Magistrini and Szollosi, 1980; Martino et al., 
1995). 
1.2.2 Fre,~;' damage 
All living organisms primarily consist of water, and during freezing, the 
solidification of water or ice formation is usually destructive or even lethal to the cells. 
Three events, which cause stress when cells are exposed to low temperature during 
freezing, were identified by Grout and Morris (1987). 
(a) the mechanical effect of extracellular ice crystal at the cell surface, especially in 
tissues with cellular interconnections; 
(b) alterations in physical properties of the solutions outside the cells including 'the 
concentration of solutes (osmotic effect), which results when proportion of the 
extracellular water Wldergoes the transition to ice 
(c) intracellular ice formation. 
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During extracellular freezing, ice formation initiates the removal of free water 
from cells to maintain osmotic equilibrium between the cells and the increasing osmotic 
strength of the bathing medium (Sakai and Larcher, 1987; Uemura and Steponkus, 1999; 
Ashworth and Pearce, 2002). This leads to cell dehydration, which can cause membrane 
lesions (Steponkus, 1984). The increase in concentration of endogenous solutes results in 
injury caused as a consequence of solute concentration either outside or inside the cells 
(Mazur, 2004). However, cells and the surrounding medium can remain unfrozen at 
temperature about -5°C because of super cooling and the depression of freezing point, 
which are influenced by the addition of CPAs. Ice forms in external medium between ­
5°C and -15°C either by chance or by deliberate seeding of ice, but cell content remain 
unfrozen and supercooled. An unfrozen external solution continues to be present due to 
solute concentration which increases as the temperature decreases and the ice phase 
grows. 
If cooling is sufficiently slow, the cells are able to lose water rapidly enough by 
exosmosis. Whist the intracellular solutes are sufficiently concentrated, supercooling is 
eliminated, and the chemical potential of intracellular water is maintained to be in 
equilibrium with that of extracellular water. As a result, the cells dehydrate and do not 
freeze intracellularly. If the cooling is too rapid, the rate at which the chemical potential 
of water in the extracellular solution is decreased much faster than the rate at which water 
can diffuse out of the cells. As a result, intracellular ice formation (IIF), which is 
inevitably lethal (Mazur, 2004) occurs. However, if the cooling rate is too slow, cells 
1 
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will experience 'solution effects' during freezing such as the exposure of cells to the 
changing hypertonic liquid environment as ice crystallizes out of solution (Mazur, 1965). 
1.2.3 Cryoprotective agents 
1.2.3.1 Mechanisms of action of cryoprotectants 
In order to survive freezing and thawing, cells must be treated with cryoprotective 
agents to avoid cell damage (Acker and McGann, 2003; Amorim et al., 2006; Hubalek, 
2003). The properties of ideal cryoprotectants are: (a) highly soluble in water, (b) remain 
in solution at low temperature, (c) penetrate cell membrane and (d) have low toxicity. 
Cryoprotectants have three main functions: 
(a) they assist in the dehydration process before extracellular ice forms; 
(b) they avoid total dehydration by reducing the water activity level within the cells; 
(c) they have a protective effect on cellular structures. 
There are two major categories of cryoprotective agents based on their ability to 
diffuse across cell membrane. The first type, penetrating cryoprotectants, which are low 
molecular weight chemicals, are able to move across cell membranes. The common 
CP As in this group are methanol, dimethyl sulfoxide (DMSO), glycerol and propylene 
glycol CPO). The cryoprotective effect is due to their colligative properties. Penetrating 
agents create the environment for a reduction of cell water content at temperatures 
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sufficiently low to reduce the damaging effect of the concentrated solutes on the cells 
(McGann, 1978). The permeating CP As produce a considerable freezing point depression 
in addition to that due to any electrolytes present vvithin the system, eventually leading to 
a ternary (CPAs-salt-water) eutectic point at a low temperature (Shepard et al., 1976). 
The second type, non-permeating cryoprotectants, are high molecular weight 
chemicals and can only be taken up by cells through endocytosis. Hydroxyethyl starch, 
polyvinyl pyrrolidone and various sugars are commonly used as non-penetrating 
cryoprotectants. These dehydrate the cells at high sub-freezing temperatures, which allow 
cells to be rapidly cooled before ice crystal can form. In general, these cryoprotectants are 
polymers forming extensive hydrogen bonds vvith water and reducing water activity. 
Some cryoprotectants with high molecular weight (>50,000) such as polyvinyl alcohol 
and Hydroxyethyl starch can alter ice crystal formation to an innocuous size and shape, 
reducing damaging effects during freezing and thavving. 
1.2.3.2 Toxicity of cryoprotectants 
Although cryoprotectants can protect cells from physical and osmotic damages, 
they can themselves be damaging to cells, especially when applied in high concentrations 
(Fahy, 1986; Arnaud and Pegg, 1988; Pegg and Arnaud, 1988; Fahy et al., 1990; 
Hubalek, 2003), The direct interaction of cryoprotectant with proteins and biological 
membranes can cause injuries such as inactivation or denaturation of specific enzymes, 
disruption of transmembrane ionic pumps, or other related perturbations of cellular 
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structure and function (Fahy, 1984; Fahy et aI., 1990). In 1983, Fahy found that the 
addition of cryoprotectant toxicity neutralisers into DMSO before freezing substantially 
reduced the freezing damage observed after thawing. DMSO appears to interact with the 
lysine-rich control enzyme for gluconegenesis, fructose diphosphatase, producing an 
effective block on glycolysis after DMSO is removed. 
1.2.4 Controlled slow cooling 
Normal procedures for controlled slow cooling involve the use of molar 
concentration of CP As in the bathing medium. The cell suspension is cooled and seeded 
with ice crystals at a temperature slightly below its freezing point. The specimens are 
cooled at an optimum rate to an intermediate subzero temperature before transfer and 
storage in liquid nitrogen at -196°C. As the temperature is lowered, molecular motion is 
reduced and stops at -130°C (glass transition temperature), and diffusion is insignificant. 
Cells are recovered from liquid nitrogen by thawing through plunging into water at a 
temperature which avoid !IF and allows devitrification without ice formation. 
Cryoprotectants are commonly removed by step-wise dilution to avoid osmotic injury, 
due to hyperosmolar freezing extenders, changes in relative solute concentration in the 
extra cellular medium during freezing and differences in the relative permeabilities of 
penetrating cryoprotectants (Wessel and Ball, 2004). 
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1.2.4.1 Membrane permeability 
Membrane permeability is a fundamental property of all cells. The first evidence 
to indicate that cells were surrounded by a lipid membrane was provided by E. Overton in 
the late 1800s (Walter, 1986). He found that substances dissolving in lipids (lipophilic) 
enter cells easier than those dissolving in water (hydrophilicllipophobic). Membranes 
function as a barrier to passive diffusion of water-soluble solutes. Knowledge of the 
permeability of the plasma membrane is important not only to design the optimal 
procedures for addition or removal of cryoprotectants or optimal cooling rates for 
cryopreservation to be developed (Gao et aI., 1995; Mazur, 1963), but also to understand 
the fundamental physical mechanisms of solute and water transport across cell 
membranes. The concentration-dependence of the hydraulic conductivity is not 
negligible; the volume response to osmotic loading is very sensitive to the partition 
coefficient of the solute in the cytoplasm, which controls the magnitude of cell volume 
recovery; and the volume response is sensitive to the magnitude of cell membrane tension 
(Ateshian et al., 2006). Three formulae to determine cell membrane permeability 
parameters have been proposed: a one-parameter (solute permeability) model (Mazur et 
aI., 1974), a classic two-parameter (water and solute permeability) model (Songpol and 
Zhanfeng, 2006; Katkov, 2000; Jacobs, 1932-1933) and a three-parameter model 
(Kedem-Katchalsky, 1958; Kleinhans, 1998), which adds a solute solvent interaction 
term ( 2: ), and has been commonly used by cryobiologists. However, modem studies 
characterising water channels (aquaporins) in biological membrane have shown that 
aquaporins selectively conduct water molecules in and out, and. unusually co-transport 
CHAPTER 1 INTRODUCTION 13 
cryoprotectants. In such circumstances, the sigma parameter is surplus to requirement, II 
1\ 
and a two-parameter formula would be more appropriate (Kleinhans, 1998). 
1.2.4.2 Cooling rate 
A cooling protocol is designed to take cells through the period of vulnerability 
with minimal damage. Slow cooling is referred to as a equilibrium freezing, if the cooling 
rate allows cells to dehydrate sufficiently to maintain the chemical potential of their 
intracellular water close to that of water in the partly frozen extracellular solution (Mazur, 
1990; Mazur et al., 2005). High levels of dehydration are attained at the same time as 
solute concentration increases, and cell water leave to equilibrate with the extracellular 
ice at equilibrium cooling rate. The increase in viscosity of the cytoplasm and depression 
in equilibrium melting point of the solution are influenced by the increase in 
concentrations of intracellular solutes. Furthermore, the cytoplasmic supercooling and 
probability of intracellular nucleation are reduced when the equilibrium melting point of 
the solution is decreased. Although the concentration and volume of intracellular 
solutions can be controlled by slow cooling rate, cell dehydration stops at some point for 
all cooling rates because the cell membrane becomes effectively impermeable at 
sufficiently low temperatures (Kaslsson et aI., 1994). Dehydration can influence the 
thermodynamic state of intracellular solution within an accessible range of temperature. 
Intracellular ice formation and cell death usually occur when cooling rates depart from 
equilibrium freezing. These consequences arise because there is insufficient time for 
water to leave the cells. 
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1.2.4.3 Seeding 
Seeding is a method to introduce pre-formed crystal nuclei into extracellular 
solution and alter the way in which crystals grow. Immediately prior to the initiation of 
the freezing program, this extracellular fluid is cooled to approximately _5° to -7°e and 
induced to freeze by a process referred to as seeding. It uses the basic conditions under 
which crystals normally grow, modified slightly. The purpose of seeding is to avoid 
supercooling and spontaneous ice formation. When ice forms in highly supercooled 
solution, crystallisation can cause damage to the cells. It has been shown that the 
probability of intracellular ice formation (IIF) is significantly increased if extracellular 
ice formation is initiated at a high degree of supercooling (Diller, 1975; Toner et al., 
1993a). This develops due to the increased cooling rate experienced by the sample as a 
consequence of thermal fluctuations caused by the release of latent heat during 
extracellular ice formation (Mazur, 1997), or from the delayed onset of freeze-introduced 
cell dehydration resulting in increased retention of intracellular water, and thus higher 
probabilities of ice formation in the cells (Diller, 1975). Two major types of damage 
usually occur when cells are exposed to extremely low temperatures: (1) Intracellular ice 
crystallization (lIe) where a relatively high water activity level is retained within cells 
during cooling, this happens when the cooling rate is too fast, and (2) solution effect 
caused by high salt concentration in intracellular solute before freezing, this happens 
when the cooling rate is too slow. Optimum cooling rate must therefore, be identified in 
cryopreservation protocol design. 
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1.2.4.4 Thawing rate 
Cells can be damaged by crystallisation of ice during cooling and warming 
because innocuous intracellular ice crystals can recrystallise if cooling is too rapid or 
warming is too slow (Mazur, 1965; Mazur, 1966; Imam and Helmy, 2005). Instead of 
simply present intracellular ice, mechanism of ice formation (Acker and McGann, 2000, 
2001, 2002; Acker et al., 2001) or size of ice crystals (Shimada and Asahina, 1975) have 
been identified as conditions that could leads to cellular damage. Some cells could 
survive with intracellular ice because ice crystal inside the cells confers cryoprotection by 
preventing the cell dehydration during subsequent slow cooling cells (Acker and 
McGann, 2002). The formation of intracellular ice alone improves the post-thaw survival 
of cultured fibroblast and epithelial cells (Acker and McGann, 2002). Confluent 
monolayer with innocuous UF shows higher survival after cooling to temperatures as low 
as -40°C (Acker and McGann, 2003). Moreover, the results in the study of post-thaw 
identification of cells show that current methods used in low temperature biology 
significantly improve with the cells forming intracellular ice during freezing (Acker and 
Croteau, 2004). 
It is thought that there is a critical size of ice crystal that the cells can tolerate 
before internal damage occurs. Although lIF is accepted to cause lethal damage to cells in 
suspension and single attached cells (Anker and McGann, 2000, 2002) , there has not yet 
been concluded weather intracellular ice formation damages to cellular components 
(Mazur and Koshimoto, 2002). Farrant (1980) has shown that survival rate can be 
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improved by rapid thawing. In spite of this, in many cases, slow thawing can give higher 
survival than rapid thawing. In a study of cryopreservation of common carp (cyprinus 
carpio) embryos, optimum survival required a slow warming rate (8°C/min) in view of 
the fact that faster rates killed the embryos (Zhang et al., 1989). Injury caused by rapid 
thawing was probably due to the presence of intracellular ice which induces osmotic 
damage from water movements at the start of thawing (Farrant, 1980). Mechanical 
stresses can influence cells and result in additional damages due to the limited thermal 
conductivity of the system in rapid warming of frozen biological systems (Vorotilin et aI., 
1991). Thus, a combination of slow warming and rapid warming (a two-step warming) 
was used to prevent the fracture (Song et aI., 2000; Taylor et aI., 2004) of the common 
carotid artery of the rabbit (pegg et aI., 1997). 
1.2.4.5 Post-thaw handling 
, 
'1 
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'IOsmotically induced swelling damage can occur when water moves into cells to 
bring back osmotic equilibrium when a thawed suspension is diluted. When the 
equilibrium is restored, cells gradually shrink because CPAs leave the cytoplasm. The 
concentration of CP As is reduced in a series of small steps to avoid the excessive osmotic 
swelling (Rall, 1993). The interval between each step is determined by the permeability 
of the cell membrane to cryoprotectants and water (Schneider and Mazur, 1984). A 
sucrose procedure is commonly used as a dilution method (Leiba, 1984), in which, after 
thawing, cells or tissues are placed into saline supplemented with 0.25M to 1 M sucrose 
(or other non-permeating solutes) to reduce the transient increase in cell volume by 
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the hypertonic extracellular solution results in a progressive shrinkage of the cells, and 
the suspending solution is replaced with isotonic saline (Rall, 1993). 
I 
I 
1.2.5 Vitrification 
Vitrification of a biological material refers to preservation of cells at the 
extremely low temperatures of liquid nitrogen (-196°C or -3200 P) in a procedure that 
avoids ice crystal formation. The extracellular solution is supercooled to the glass 
transition temperature and solidified into glass-like amorphous solid. Vitrification was 
first considered for cryopreservation by Luyet (1937). and the first successful 
cryopreservation of mouse embryos by vitrification was performed by RaIl and Pahy 
(1985). 
There are five approaches to vitrification (Steponkus et al., 1992): 
(1) Equilibration of the cells or tissues in a penneating cryoprotectant solution; 
(2) Dehydration of the cells or tissues in a concentrated solution that will vitrify; 
(3) Plunging the cells or tissues in to LN2; 
(4) Warming the cells or tissues; 
(5) Dilution of the vitrification solution and remove of cryoprotectants from the 
cytosol. 
'I 
I 
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For good vitrification, it is important to cool as fast as possible to the glass 
transition temperature, which is assumed to be around minus 125°C after perfusion is 
complete. At this stage, the system almost completely loses its fluidity and becomes a 
solid liquid, which is said to have vitrified. Vitrification has been successfully used in the 
preservation of tissues (Annitage, 1986; Jutte at al., 1986; Baicu et al., 2006; Shannon et 
al., 2006), blood cells (Boutron, 1992), plant somatic embryos of Asparagus officinalis 
(Uragami et al., 1989), drosophila melanogaster embryos (Steponkus et al., 1990; Mazur 
et al., 1992a), oocytes and embryos of mouse (Hsu et al.' 1986; Bielanski, 1987; Friedler 
et al., 1987;), hamster (Critser et ai., 1986), rat (Kono et aI., 1988), rabbit (Kobayashi et 
1., 1990 Cervera and Garcia, 2003; Hochi et al., 2004), goat (Yuswiati and Holtz, 1990), 
sheep (Gajda et al., 1989; Szell et a!', 1990), cow (Massip et al., 1986; Van et al., 1989; 
Vajta et al., 1998), pig (rubinsky et al., 1991; Nagashima et aI., 1996), and human 
(Trounson, 1986; Saito et al., 2000). 
'.I 
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However, vitrification cannot prevent all damage due to chilling or freezing 
injury. The process of preparing for vitrification can itself cause damage because it 
requires high cryoprotective concentrations, which may induce adverse and toxic effects. 
The concentrations of solutes used in a vitrifiable solution are substantial (excess of 30% 
w/v), and serious consideration is always taken of the toxicity of solutes used 
(MacFarlane and Forsyth, 1990). Although the difficulty with multi-cellular tissue mass 
cryopreservation can be overcome in some cases by vitrification, there is always a risk of 
cracking of the glass in the vitrified state. 
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1.3 Applicatio~ >; of .·yob.:...ogy 
1.3.1 Applications in biomedicine 
The applications of cryobiological teclmiques are important in assisted reproduction due 
to the increase in demand for both human conception and animal breeding. The 
cryobiological techniques have propelled the challenges of tissue collection, 
preservation, and banking to the research forefront. Cryopreservation of living tissue, 
including blood, bone marrow, cornea, and skin is currently practiced in an attempt to 
decrease the shortage of supply of medication. The successful cryopreservation of bone 
marrow cells was performed in late 1970s (Thomas, 2000). As a result, autologous bone 
marrow transplantation has become a widely available therapy to treat patients diagnosed 
with leukaemia, aplastic anaemia and lymphomas needing chemotherapy. With the 
cryobiology techniques, full-thickness corneas was first stored by freezing following 
pretreating them with 15% glycerol (Eastcott, 1954). Kaufman and Capella (1968) also 
reported successful preservation of donor corneas for periods up to one year by 
cryopreservation. Although corneal cryopreservation is not a common procedure, there is 
continual interest in this area in various countries (Ehlers and Sperling, 1983, Delbosc et 
aI., 1984 and Ruusuvaara, 1988). With the use of different cooling rates, transfer 
temperatures and cryoprotectants, it is possible that the corneal cryopreservation will 
become a more routine procedure in the future. Moreover, advances in cryopreservation 
allow tissue banking of skin allografts produced from a deceased donor. Freezing of the 
graft gives it a shelf life of at least six months, as opposed to a few days when not 
20 CHAPTER 1 INTRODUCTION 
cryopreserved. In surgery, there is a widespread use of cryopreserved allografts with 
excellent results (Moriyama et al., 200 1, Vesely et al.,1990 and Eugene and Gerota, 
1983). 
Human egg and embryo freezing has become a well-established technology in human 
assisted reproduction arising from cryobiology. In 1983, the first successful pregnancy 
occurred arising from cryopreservation and thawing of an 8-cell human embryo in 
DMSO, thawing and transfer of an eight-cell embryo (Trounson & Mohr, 1983). There 
has been a significant resurgence of interest in the benefits of cryostorage of female 
gametes in the last few years. Cryostorage of a woman's oocytes has advantages for: (a) 
formation of donor egg banks facilitating and reducing the cost of oocyte donation, (b) 
provision of egg cryostorage for women wishing to delay their reproductive choices and 
(c) cryopreservation of ovarian tissue taken from women who undergo therapy that may 
threaten their reproductive health. Egg and ovarian tissue cryopreservation is becoming 
more routine but less successful than embryos. However, there are several reports of 
successful cryostorage of donated human oocytes using this approach (Polak de Fried et 
al., 1998 and Tucker et a1., 1998a). In addition, the use of frozen donor oocytes post-thaw 
for ooplasmic transfer has been reported to be a successive application in thawed 
ooplasmic donation (Lanzerdorf et al., 1999). The developments in cryobiology have 
provided many valuable techniques in other areas such as cryopreservation of the 
preimplantation human embryo, sperm cryopreservation, cryopreservation of ovarian 
tissues and blastocysts. Although cryopreservation ofhuman embryos has become a well­
established technology in assisted human reproduction, the best cryostored stage of 
pre implantation embryos is unclear. 
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The first successful of human blastocyst cryopreservation came from culture in a 
simple salt solution (Cohen et aI. 1985; Fehilly et al. 1985). The use of a combination of 
glycerol and sucrose as cryoprotectants to freeze "spare" expanded blastocysts was 
investigated in attempts to improve the pregnancy rates and convenience of 
cryopreserving blastocysts (Menezo et aI., 1992). In 1997, the original cryopreservation 
protocol (1992) for blastocysts was modified to be more convenient and successful 
(Menezo and Veiga, 1997). This protocol was applied to bovine oocytes and has been 
used with human oocytes with successful outcomes (Kuleshova et al., 1999). The initial 
trials were carried out with human blastocysts (Lane et aI., 1999). The aim of blastocyst 
cryopreservation is to maximise the potential viability of each embryo thawed and 
replaced. 
1.3.2 Application in conservation 
Genetic resource banking is established to manage and protect many species from 
threatened populations in secure conditions. Gametes and embryos are stored for a 
breeding program in the future (Holt et al., 1996a). The possible reasons why particular 
species are chosen and included in animal genetic resource banks are shown in table 1.1 
(Bennett et aI., 2001). 
I 
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Table 1.1 Possible goals for animal Genetic Resource Banks 
Economic 	 to preserve rare domesticated breeds 
to enable multiple inseminations from the fittest males 
to increase productivity of food sources for human consumption 
to help conserve diverse wildlife resources 
Political 	 to help meet demands of conservation and environmental legislation 
to conserve flagship species or national emblems 
to meet the demands of non-governmental organisations 
Social 	 to conserve species of cultural or religious significance 
to conserve species of educational or recreational importance 
to conserve species of known or suspected medical importance 
Scientific 	 to conserve species that support pure or applied research 
From Establishing animal germplasm resource banks for wildlife conservation: Genetic, population and evolutionary 
aspects, Peter, M. B." 2001. 
1.4 Current status of aquatic species cryopreservation 
The vast majority of aquatic genetic resources are found in wild populations of 
fish, invertebrates, and aquatic plants. The number of species in aquaculture is growing 
and several important species rely on the collection of brood stock or seed from natural 
popUlations. There are several options to conserve genetic diversity. In general, in situ 
conservation (providing the minimal conditions required to maintain genetic variety in its 
I 
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natural state) is preferred to conserve the breeds. However, conservation through sperm 
cryopreservation is also selected to preserve rare breeds and used widely with 
commercial strains. 
1.4.1 Sperm 
The sperm of many fish species can be successfully cryopreserved with similar 
successes to that achieved with domestic livestock. Sperm cryopreservation is one way to 
overcome the problems associated with brood stock supply. More than 200 fish species 
with external fertilisation have been tested for sperm cryopreservation (Blesbois, 2003). 
Sperm cryopreservation can be used to provide sperm on demand and simplify the timing 
of induced spawning. Storing frozen sperm also helps to eliminate the need to maintain 
live males and protect valuable genetic lineages such as endangered species, research 
models or improved fanned strains. The developed bloodstocks with enhanced 
characteristics such as growth rate and disease resistance can be represented in the sperm 
collections. The insemination ratio used is different according to species and procedure 
) 
between 104_107 spermatozoa per egg. In African catfish, semen can only be obtained by 
testis destruction or death of the male. However, a single male can produce semen 
enough to generate plenty of progeny (Viveiros, 2000). Thus, storage of one single vial or 
straw would be adequate enough to provide progeny for gene~bank purpose. Successful 
cryopreservation protocols have been described by several groups, including Chao and 
Liao (2001), Cabrita et al. (2003), Suquet et al. (2000), Babiak et al. (1997) Horvath et a1. 
(2003), Lahnsteiner et al. (2000), Cloud (2000) and Owo (2000). In consequence, 
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cryopreserved sperm of aquatic species may become increasingly commercially 
important. 
1.4.2 Oocyte and embryo 
Although both slow cooling and vitrification are effective for cryopreservation of 
embryos in mammals, embryo cryopreservation in aquatic species, especially fish, is not 
fully viable due to the large size, the high lipid content and the polar organisation of the 
ova and the early embryos (Hagedorn, 2004). These factors cause problems associated 
with injuries initiated during the cooling and thawing processes. The large size of the 
mature egg and embryo results in low surface area to volume ratios. This reduces the rate, 
at which water and cryoprotectants can move into and out off the eggs and embryos 
(Mazur, 1984). The embryos of many fish species are also reported to have stage-
dependent chilling sensitivity such as brown trout (Maddock, 1974), carp (Dinnyes et al., 
i · .1998;) and zebrafish (Zhang and Rawson, 1995). From most of these studies, the 
" 
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developmental stage beyond 50% epiboly is revealed to be less sensitive to chilling. In 
fish embryo preservation, methanol, glycerol, ethanediol, and propane-I, 2-diol are 
commonly used as cryoprotectants with typical concentration ranges of 1 to 2M (Adam et 
aI., 1995; Robertson et aI., 1988; Zhang et al. , 1993). Post-thaw survival of blastomeres 
was demonstrated with successful results in many aquatic species such as rainbow trout, 
carp and medaka (Blesbois, 2003). 
CHAPTER 1 INTRODUCTION 25 
1.4.3 Somatic cells 
Long-term storage of somatic cells and tissues is of increasing importance to the 
research and biomedical fields. Cryopreservation of cells and tissues is useful, for 
example, for the establishment of organ banks; the long-term storage of cell lines to 
provide an unchanging population of cells; and the storage of populations of cells for 
research or medical purposes. This is the case when an epidemic outbreak of disease in an 
animal population requires the genome to be collected before the stock is slaughtered. 
Anal fins from gold fish (Carassius auratus) were studied to facilitate banking of fish 
somatic cells (Mauger et al., 2006). In cloning, cell culture from fin explants of bighead I 
carp (Aristichthys nobilis) (Liu et aI., 2002) and medaka (Oryzias Jatipes) (Ju et aI., 2003) t
Ie 
~' 
were used, and many investigations were conducted on Cyprinidae, including goldfish , 
(Sun et al., 2005) and zebrafish (Lee et aI., 2002). Cryopreservation of cultured fish cells, 
...... F",J,;: ;, 
mainly cell lines have been studied in different fish species, including bluegill sunfish 
(Zhang and Rawson, 2002), goldfish (Chou et al., 1989) and sturgeon (Wang et al., 
2003). Cell lines are used for many purposes. Viable cell line cultures of fish were first 
reported by Wolf (1962). Many fish cell lines were primarily used for viral diagnosis, and 
they are still extensively utilized in diagnostic procedures (Fryer and Lannan, 1994). A 
black sea bream fibroblast cell line has been used as an in vitro model for stress protein 
studies (Zhou et al., 2003). Fish cell lines also play an important role in studies related to 
toxicology, genetic regulation and expression, and DNA replication (Babich, 1991; BoIs, 
1991; Hightower, 1988). Fish cell lines used in laboratories from 74 species providing 11 
159 cell lines were reported by Fryer and Lannan (1994). Some cell lines originated from 
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fish tumours (Kelly, 1980; Matsomoto, 1980; Wakamatsu, 1984; Wolf, 1980; Fijan, 
1983; Lannan, 1984; Etoh, 1988; Hightower, 1988; Fernandez, 1993). Most fish cell lines 
were derived from fins in primary culture (Fryer and Lannan, 1994; Sumihiro, 2003; 
Wang, 2003; Mauger, 2006; Wazir, 2006). 
1.5 Use of zebrafish (Danio reria) as a model 
Zebrafish was firstly recognised as a model for studying vertebrate development 
and genetics by George Streisinger (1981). They are an excellent system for 
developmental biologists and geneticists (Westerfield, 1989; Detrich et aI., 1999) and 
have become one of the most important vertebrate models for the studies of development 
and genetics. Zebrafish exhibit ideal model features (Rall, 1993): 
(a) 	small adult size; 
(b) short generation interval; 
(c) 	both fish and embryos can be maintained in vitro throughout the entire life cycle; 
(d) eggs, embryos and spermatozoa can be available daily ( non-seasonal breeding); 
(e) 	appropriate reproductive biotechniques are available (e.g., oocytes, semen and 
embryo collection, embryo micro-manipulation). 
Zebrafish development is very similar to the embryogenesis in higher vertebrates 
including humans. The oocytes also fertilise externally and develop outside of the 
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maternal body. Additionally, their eggs and embryos are transparent, providing 
visualisation of organ systems of the embryo as they develop. For instance, the internal 
organs such as the brain, the heart, the inner ear, and the muscles of the trunk can be seen 
in 24 hour old zebrafish larvae. 
The zebrafish embryos develop very rapidly: all the major organs form in the first 
24 hours after fertilisation. The fish hatch and start to look for food in the third day of 
development. Sexually mature zebrafish can lay up to 200 eggs per week. These 
advantages: the rapid embryonic development, the transparency of the embryos and the 
large number of offspring make the zebrafish an ideal model organism to study various 
aspects in vertebrate development. 
1.6 Purposes of the study 
The project seeks to develop protocols for the collection and preservation of 
viable tissue explants from fish, for subsequent use in establishing cell cultures for 
cryobanking. Successful procedures will then be available for cryobanking of cell lines 
from genetically important and endangered fish species. 
-
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2.: .. ntroduction 
Three main areas of study were covered by the project: toxicity of cryoprotectants 
to liver cells of zebrafish; short term storage of fresh liver cells; and cryopreservation of 
fresh and stored liver cells. All the experimental work was done in LIRANS' 
laboratories, University of Bedfordshire. 
2.2 General Methods 
2.2.1 Maintenance of Zebrafish (Danio rerio) 
2.2.1.1 General information 
Adult zebrafish (3 - 4 month old) were acquired from Aquasca.pe, Binningham. 
England. They were reared in filtered and aerated 45 litre tanks (28 x 28 x 58 em) at 
27°C with a light/dark cycle of 12112. Fifteen to twenty fish were held in each tank. 
Water in the fish tanks wa.s renewed every four weeks. 
I 
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2.2.1.2 Feeding 
Adult fish were fed three times a day with 'TetraMin' (Tetra, Germany) fish food 
(ingredients: fish and fish derivatives, cereals, yeast, vegetable protein extracts, molluscs 
and crustaceans, oils and fats, algae, various sugars, EEC permitted colorants and 
preservatives), and once at noon with brine shrimp. The maximum amount of the food 
fed to the fish was the amount that the fish could eat within five minutes in order to avoid 
over feeding. 
2.2.2 Chemicals 
The chemicals used in this study are analar. They were provided by Sigma-
Aldrich Company Ltd. (Gillingham, UK) with exception of NaCI from Fisher Scientific 
UK Ltd. (Loughborough, UK) and L-glutamine from BDH Chemical Ltd. (Poole, UK). 
Stocks of aqueous solutions and media were prepared ahead of time except FDA-PI, 
which was prepared fresh. 
2.2.3 Tissue collections and cell digestion 
Donor fish with a healthy appearance were anaesthetised with a lethal dose of 
tricane (0.6 mg/ml) and decapitated. The gut of the fish was carefully discarded. The 
livers were dissected with sterile instrwnents under a stereo-microscope. The livers were 
put in 1.5ml Eppendorf tubes and rinsed three times for 15 minutes each in 1 rol PBS 
supplemented with Penicillin (200mg/L), Streptomycin (200mgfL), Gentamycine 
:·11
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(400mg/L), and Amphotericine B (2.Smg/L). After each 15 minute rinsing, the liver 
tissues were centrifuged, and supernatant solution was removed from the tubes before the 
pellet was resuspended in the new solution. 
After the livers had been washed three times, they were gently digested for 5 
minutes in Iml L-15 supplemented with Hepes (5.958 gIL), NaHC03 (0.42 gIL), 
Gentarnycine (100 mglL), Amphotericine B (2.5 mg/L), L-glutamine (0.374 giL), Fetal 
bovine serum (10%), and Collagenase (0.2 gIL). The liver cells were disaggregated by 
pipette action. After the cells were separated, they were centrifuged at 12,000 rpm/min 
for 5 seconds (Anderman Centrifuge 5414, Eppendorf, Germany). L-15 with supplements 
was removed, and the liver cells were then rinsed with Iml PBS. 
2.2.4 Cryoprotectant dilution method 
One step addition of cryoprotectants was used in this study. In order to remove 
the cryoprotectants used in the study, two approaches were used. The one step dilution 
was applied for removal of cryoprotectants in assessing their toxicity to liver cells of 
zebrafish. A three-step dilution was used to reduce osmotic shock of cryoprotectant 
removal in the study of cryopreservation of fresh and stored zebrafish liver cells. Samples 
with lOOlll cryoprotectant solution were diluted with 50lll PBS followed by 150111 and 
300111 of PBS. The samples were left at room temperature for 5 minutes between each 
PBS addition. The final volume was 600111. All solutions were removed for viability 
assessment after centrifugation. This method was carried out subsequent to 
cryopreservation. 
I 
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2.l~5 Cell viahility assessment 
2.2.5.1 Trypan blue- membrane integrity 
Trypan blue is commonly used as a vital stain to selectively colour dead cells. 
Trypan blue cannot penetrate the intact membrane of viable cells, which therefore do not 
satin. However, dead cells are stained blue in colour, as they allow the dye to penetrate. 
Since living cells or tissues with intact cell membrane are excluded from staining, trypan 
blue is designated as a dye exclusion method of assessing the viability of cells or tissues. 
Preliminary studies of cell viability assessment were done using 2% trypan blue 
solution to stain the liver cells. The viability of the cells was evaluated in terms of the 
percentage of viable cells after different CPA treatments. All samples were centrifuged to 
remove bathing solution before the assessment. Liver cells were stained with 1 OO~l of 2% 
trypan blue for 5 minutes at room temperature. Viable cells and nonviable cells were 
clearly distinguishable (Fig. 2.1). The number of the viable and nonviable cells were 
counted on a haemocytometer under a microscope, and compared with positive controls. 
Each sample was counted three times. Results were expressed as the percentage of viable 
cells. 
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2.2.5.2 FDA-PI (Fluorescein diacetate-Propidium iodide) 
Fluorescein diacetate is used to differentiate viable cells and nonviable cells in a 
fluoromatic assay. Absorption is 494 nm, and the emission is 520 nm. Viable cells are 
fluorescently stained because they have esterase activity, which is lost in dead cells. Once 
the cells take up the FDA, the esters are hydrolysed by intracellular esterases, and the 
fluorescent products accumulate. In this study, FDA stock solution was prepared with 5 
mg FDA in 1 ml acetone and stored in the dark at -20o e. FDA working solution needed 
to be freshly prepared by adding 5~ FDA stock solution to 1ml PBS (final concentration 
of25~g FDNml). 
Propidium iodide (PI) is commonly used to identify the dead cells in a population 
because it is membrane impenneant and is generally excluded from viable cells. When 
bound to nucleic acids, the absorption maximum is 53511m, and the fluorescence emission 
maximum is 61711m. In this study, PI was used as a counterstain with FDA. Propidium 
iodine stock solution was prepared with Smg PI and Iml PBS. PI working solution was 
5~ PI together with Iml PBS. To stain with FDA-PI, lOOJ.ll of each working solution was 
added directly to the resuspended cells. 
In this study, FDA was used in a double staining procedure in combination with 
PI to assess cell viability in cell suspension. To stain with FDA-PI, 100~1 of each 
working solution was added directly to the resuspended cells. The viability of the cells 
after staining with FDA-PI and being held in the dark for 5 minutes was evaluated by 
,,, ~ 
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counting 100 cells by a fluorescent microscopy. Viable cells stained bright green with 
FDA and nonviable cells stained bright red with PI were clearly distinguishable (Fig 2.2). 
Each sample was counted three times. Results were expressed as the percentage of viable 
cells. 
2.2.6 Data analysis 
2.2.6.1 Normalisation of liver cell survival 
There were variations in the viability of control cells as determined by TB and 
FDA+PI. Therefore, experimental survival was normalised according to the viability of 
the corresponding control as follows: 
Normalised survival (%) = experimental survival (%) x 100 
untreated control survival 
2.2.6.2 Replication and statistical analysis 
In cryoprotectant toxicity studies and storage of fresh cell tests, three 
measurements were made (n = 3) for each experiment. For cryopreservation studies, three 
replicates with three measurements were used. 
In the study, the 2-tailed student's t-test, assuming unequal variance's was used to 
determine the differences between results from two groups such as two different treated 
groups or between control and treated groups. The statistically significant P value was 
less than 0.05. Variances from ANOVA (replications with one factor) calculation were 
T: 
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used to analyse the inclusive effects related to the studies. SPSS version 12.01 for I 
Windows (SPSS inc., The Apache Software Foundation) was used to calculate means, I 
I 
,! 
standard errors, and all other values for t-test and ANOVA. The standard error of the 
!, 
mean (SEM) shown by a bar in graph is indicated by the '±' values. I
, 
2.3 Toxicity of cryoprotectants to liver cells of zebrafish I 
2.3.1 Selection of cryoprotectant I 
The cryoprotectants used in this study are listed in Table 2.3. There were two 
types of cryoprotectants used: penetrating and non-penetrating cryoprotectants. 
Table 2.2 Cryoprotectant concentrations and exposure times used in the study 
Cryoprotectant 
Penetrating CPA: 
Methanol 
DMSO 
PG 
Non-penetrating CPA: 
Sucrose 
Concentration 
1M, 2M, 3M, 4M 
1M 
1M 
0.05M,0.lM 
Penetrating + Non-penetrating CPA: 

Methanol + 

Sucrose 2M+0.05M 

exposure time 
10,20,30 min 
10 min 
10 min 
10,20, 30 min 
10, 20, 30 min 
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2.3.2 Effect of cryoprotectant concentrations and exposure time 
After digestion (Section 2.2.3), liver cells were washed once with Iml 
unsupplemented PBS. They were centrifuged, and the washing solution was removed. 
They were then transferred into the test tubes containing lOOll1 of different 
cryoprotectants and left for selected times in a range of CPA concentrations in PBS 
(Table 2.3). After cryoprotectant treatment, the liver cells were centrifuged, and the 
cryoprotectants were removed. They were washed several times with Iml PBS. The 
viability assessment was the same as described above (Section 2.2.4). Control liver cells 
were treated in the same way except that they were not exposed to cryoprotectants. 
2.4 Stora,ge of fresh cells (tissll.e and disaggregated cell mass) of 
zebrafish 
After the liver cells were digested (Section 2.2.3) and washed once with PBS, 
they were held in Eppendorf tubes with 1mL bathing medium. Three different bathing 
media were investigated: (i) PBS, (ii) PBS supplemented with Penicillin (200mg/L), 
Gentamycin (400mg/L) and Ampotericine B (2.5mglL) and (iii) medium C (hnl L-15 
supplemented with Hepes (5.958 giL), NaHC03 (0.42 giL), Gentamycine (l00 mg/L) , 
Amphotericine B (2.5 mglL) , L-glutamine (0.374 gIL) and Fetal bovine serum (10%)). 
The liver cells in the different bathing media were held at 4°C and 6°C for 12,24, and 48 
hours. Viability of the cells was assessed using TB (Section 2.2.4.1) after 12, 24, and 
'. ',',
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48hrs of storage. After the storage, the liver cells were treated with 2M methanol for 10 
minutes (Section 2.3.2) and cryopreserved (Section 2.5). The viability assessment was 
carried out again after cryopreservation. 
I 
I2.5 Cryopreservation of fresh and stored liver cells of zebra~~b 
2.5.1 Cryopreservation 
After cell digestion and treatments with cryoprotectants (Section 2.3.2), the liver 
cells with cryoprotective solution were stored in cryo-straws and placed in the controlled 
cooler (KRYO 10, Series II, Planer Products Ltd., England). The start temperature was 
20°C. The freezer was set to lower the temperature in the sample chamber by 5°C per 
minute until the temperature reached -7.5°C. The temperature was then held for 15 
minutes, and seeding was carried out at this point. Subsequently, seeding was performed 
manually by touching the straws at the top column of media with liquid nitrogen (LN2) 
cooled forceps, until the media turned white. This usually took 3-5 seconds. The 
temperature was then lowered by 0.3°C per minute until -40°C, then by 2°C/min and held 
for 10 minutes at -80°C. The cells were then plunged into LN2 and held in LN2 for 10 
minutes (Table 2.4). The cooling protocol was based on existing LIRANS procedures for 
successful cryopreservation of zebrafish blastomeres. 
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2.5.2 Thawing 
After removal from liquid nitrogen, the cells were immediately thawed by 
plunging into a 27°C water bath for 10-15 seconds. All100~ samples were ejected into 
the centrifuge tubes and diluted with 50111 PBS for 5 minutes, followed by 150J.ll PBS for 
5 minutes and 300).!1 PBS for another 5 minutes. Then they were centrifuged, and the 
bathing solution was removed before immersion in 200).!l PBS. Post thaw viability 
assessment (Section 2.2.4.1) was carried out using Trypan Blue. 
, i 
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Table 2.3 Cryopreservation protocol 
Cell + CPAs 

(2M MeOH+O.05M Sucrose) 

10, 20, and 30 Min 

Put in the controlled cooler 20°C 
-7.5°C Hold for 15 min (Seeding) i 
-ao°c Hold for 10 min 
Plunge into LN2 

-196°C for 10 min 

Thawing 

27°C Water bath for 10-15 sec. 
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CHAP~'ER 3 C1<YOPF. OT .:~Tf -T T .XICITY 
3.:. Introduction 
A previous study of the effect of cryoprotectants on non-freezing storage of 
zebrafish embryo at ooe and subzero temperatures (Zhang and Rawson, 1995) indicated 
that methanol was an optimal cryoprotectant when compared with DMSO or PG, and the 
presence of sucrose slightly enhanced cooling tolerance of the embryo. In the studies on 
cryopreservation of zebrafish (Dania rerio) vitello genic oocyte using controlled slow 
cooling (Plachinta et al., 2004), methanol, DMSO and PG were applied to the oocytes, 
and methanol appeared to be the most effective cryoprotectant. However, DMSO 
appeared to be a better cryoprotectant than methanol in the studies on membrane integrity 
and cathepsin activities of zebrafish (Dania rerio) oocytes after freezing -196°C using 
controlled slow cooling (Zhang et al, 2005b). In previous studies related to successful 
cryopreservation, 10% and 13% DMSO were selected to treat epitheloid and fibroblastic 
cells of Asian seabass Lates calcarifer (Wazir et al., 2006) and fin cells of Goldfish 
Carassius auratus (Mauger et al., 2006). 
Cryoprotectants are used to reduce the injury of cells during freezing and thawing. 
Whilst cryoprotective agents can protect the cells from alteration of cellular and 
environmental geometry, a variety of cryoprotectants can themselves be damaging to 
cells, especially when used in high concentrations (Fahy, 1986; Arnaud and Pegg, 1988; 
Pegg and Arnaud, 1988; Fahy et al., 1990). In order to optimise the pre-treatment 
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procedures for liver cell cryopreservation, experiments were carried out to investigate the 
sensitivity of liver cells to different cryoprotectants prior to cryopreservation studies. In 
the following experiments, both penetrating and non-penetrating cryoprotectants were 
studied. Commonly used cryoprotectants, methanol, dimethyl sulfoxide (DMSO), 
propylene glycol (pG) and sucrose were selected for use in the study. Two different 
viability tests were used to assess liver cell survival: trypan blue (TB) staining and 
fluorescein diacetate - propidium iodide (FDA-PI) staining. 
3.2 Results 
3.2.1 Sensitivity of zebrafish liver cells to methanol 
Liver cells of zebrafish were treated with different methanol concentrations for up 
to 30 minutes to observe cell tolerance. The survival of the liver cells assessed with TB is 
shown in Fig 3.1, while Fig. 3.2 shows the liver cell survival assessed with FDA-PI. 
Liver cells assessed with TB were the same batch as those tested with FDA-PI. The 
viability of control cells was measured before liver cells were treated with 
cryoprotectants at room temperature. The FDA-PI test was found to give a significantly 
lower percentage ofnonnalised viable cells than the TB method. 
,,' 
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The toxicity studies from both TB and FDA-PI assessments show that the 
zebrafish liver cells can tolerate 2M methanol for up to 30 minutes at room temperature 
with normalised survival more than 50%. The liver cells can tolerate 2M methanol for 10 
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minutes at room temperature with normalised survival of 91.47 ± 1.3% by TB assessment 
and 83.26 ± 2.4% by FDA-PI assessment. The experiments revealed a reduction in liver 
cell survival as the concentration and exposure time for methanol increased. Therefore, 
the 2M methanol was limited to 10 minutes to get the highest survival in subsequent 
experiments with liver cells of zebrafish. However, greater than 30% of liver cells 
assessed with FDA-PI survived exposure to 4M methanol for 30 minutes. 
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3.2.2 Sensitivity of zebrafish liver cells to dimethyl sulfoxide and propylene 
glycol 
The toxicity of the cryoprotectants, DMSO and PO to liver cells of zebrafish was 
investigated, and the results of survival compared to those obtained in the study of 
Illethanol toxicity. Liver cells ofzebrafish were exposed to 1M DMSO or 1M PO at room 
temperature for 10 minutes. Viability assessment was carried out using both the TB and 
the FDA-PI staining methods. 
Comparisons of survival of zebrafish liver cells following exposure to either 
DMSO or PO at room temperature for 10 minutes showed the two cryoprotectants to 
have very similar toxicities. As shown in Fig. 3.3b, the normalised survival of liver cells, 
as determined by TB staining for 1M DMSO was 75.97 ± 1.8% and for 1M PO was 76.08 
± 4.6% after 10 minute exposure. The results from the FDA-PI assessment revealed that 
approximately 50% of liver cells of zebraf"ish did not survive exposure to 1M DMSO or 
PG at room temperature for 10 minutes (Fig. 3.4b). No further studies of increased 
concentration or increased exposure time of DMSO or PO were investigated because they 
-were more toxic to the liver cells than methanol. The liver cells survived the 10 minute 
exposure to 2M methanol, 1M DMSO and 1M PO with normalised survival of 83.26 ± 
2.4%,48.07 ± 0.6% and 48.46 ± 3.0%, respectively. 
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3.2.3 Sensitivity of zebrafish liver cells to sucrose 
Non-penetrating cryoprotectants are thought to act by dehydrating and shrinking 
the cells at high sub-freezing temperatures, thereby allowing them to be rapidly cooled 
before the injury of slow cooling can lead to extensive damage. These compounds are 
generally polymers that fonn extensive hydrogen bonds with water, reducing the water 
activity to a much greater extent than would be predicted by their molar concentration. 
Fig. 3.5 shows liver cells of zebrafish to be not very sensitive to 0.05M sucrose 
when assessment was carried out using the TB test. The toxicity studies revealed that the 
liver cells can tolerate 0.05M sucrose for 30 minutes at room temperature with a 
normalised survival rate of 78.39 ± 0.6% (Fig3.5b). Moreover, approximately 70% of 
liver cells of zebrafish survived exposure to 0.1M sucrose treatment for 30 minutes. 
Although nearly 70% liver cells survived exposure to 0.1M sucrose for up to 30 minutes, 
only survival from 0.05M sucrose treatment was assessed with FDA-PI test. No further 
FDA-PI assessment in viable cells from 0.1M sucrose treatment was carried out because 
the studies were intended to maximise the cell survival, and FDA-PI test always resulted 
in lower viability of cells than the TB test. As shown in Fig. 3.6b, survival significantly 
decreased with increasing exposure time. FDA-PI assessment showed more than 60% 
I survival after a 30 minute exposure to O.05M sucrose. 
I 
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Based on these high survival rates of liver cells, sucrose was chosen to treat the 
cells together with methanol for further study of cryoprotectant toxicity. Since methanol 
is a penetrating CPA, and sucrose is a non-penetrating CPA, the combination of 2M 
methanol and 0.05M sucrose was applied to the liver cells in an attempt to yield higher 
survival rates. 
3.2.4 Sensitivity of zebrafish liver cells to sucrose +MeOH 
The cryoprotective actions of the combination of 0.05M sucrose and 2M methanol 
were conducted to compare with the results obtained in the earlier cryoprotectant toxicity 
tests. A high number of survival diminutions from the FDA-PI assessment occurred when 
0.05M sucrose and 2M methanol were applied to liver cells ofzebrafish (Fig. 3.7b). Less 
than 50% of cells survived exposure to 0.05M sucrose + 2M methanol for 10 minute 
treatment. Exposure up to 20 minutes resulted in no significant additional loss of 
viability, as determined by FDA-PI staining. However, liver cells can tolerate 0.05M 
sucrose together with 2M methanol at room temperature with normalised survival of 
47.66 ± 3.8%,46.49 ± 2.9% and 44.53 ± 2.03% for 10,20 and 30 mins, respectively. 
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3.3 Discussion 
Under the same conditions, the normalised survival of liver cells of zebrafish as 
determined by TB assessment was always higher than the survival indicated by the FDA­
PI method. FDA-PI was more reliable for assessing liver cell viability as it assesses a 
function inside the cells after cryoprotective treatment (2.2.5.2). Moreover, the TB test 
might not be ideal since it can only assess the membrane integrity as apposed to the 
physiological status of the whole cell. However, the TB method was applied to get 
comparative results to FDA-PI method in all cryoprotectant studies except in the test of 
sucrose + methanol toxicity. These studies showed that the toxic effect of cryoprotectants 
on liver cells of zebrafish generally increased with increasing concentration and exposure 
time. 
The results from the study of methanol toxicity reveals that liver cells of zebrafish 
showed some sensitivity to 2M methanol after only 10 minute exposure. However, a 
proportion of liver cells were able to survive 4M methanol treatment for up to 30 
minutes. The normalised survival provided by TB assessment showed that more than 
70% of zebrafish liver cells tolerated 4M methanol for up to 30 minutes. However, FDA­
PI assessment indicated that only 57.14 ± 3.5%,51.83 ± 3.9% and 58.77 ± 8.0% of liver 
cells remained viable after 30 minute exposure to 2M methanol, 20 minute exposure to 
3M methanol and 10 minute exposure to 4M methanol, respectively. 2M methanol was 
selected to compare with others CPAs because of the results obtained by FDA-PI 
analysis, and it appeared to be the best protocol to adapt in future cryopreservation 
studies. 
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Comparative studies with 1M DMSO and PG exposure for 10 minutes were 
evaluated. There was no significantly different effect on the survival levels, given by TB 
or FDA-PI, between 1M DMSO and PG. Although the normalised survival of liver cells 
given by TB assessment was higher than 50% in both DMSO and PG treatments, FDA-PI 
test proved that 1M DMSO and PG were toxic to liver cell of zebrafish since 48.07 ± 
0.7% and 48.46 ± 3.0% of normalised survival could tolerate a 10 minute exposure to 
DMSO and PO, respectively. 
Toxicity of sucrose to zebrafish liver cells was investigated at room temperature 
for up to 30 minutes. The results demonstrated that the cell survival assessed by the TB 
test was reduced due to the increase in sucrose concentrations and exposure time. 
However, no significant difference (p > 0.05) was found in the normalised survival of 
liver cells after exposure to 0.1 M sucrose for 10 and 20 minutes. Also, no significant 
reduction (p > 0.05) in liver cell survival was found between 20 and 30 minute exposure 
to 0.05M sucrose. Although from the TB test, the exposure to O.lM sucrose for 30 
minutes gave a normalised survival of 69.96 ± 2.5%, the FDA-PI stain was only applied 
to the cell survival from 0.05M sucrose treatment to obtain the highest viable cell rate. A 
significant reduction (p < 0.05) in the cell survival was seen between the TB and FDA-PI 
tests. Results from the FDA-PI test showed that liver cells were able to survive exposure 
to 0.05M sucrose for 10, 20 and 30 minutes with normalised survival rates of 78.13 ± 
5.5%,66.02 ± 9.1% and 44.53 ± 19.7% respectively. Consequently, further studies were 
investigated on the toxicity of 0.05M sucrose + 2M methanol to fmd the optimal CPA 
and concentration to treat liver cells. 
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The above results on cryoprotectant toxicity indicated that methanol + sucrose 
may be a useful cryoprotectant combination which is comparable to methanol only. 
Therefore the sensitivity of liver cells was investigated following 2M methanol + 0.05M 
sucrose treatment. In this study, only FDA-PI test was applied to assess the viability of 
liver cells. The liver cells were able to survive exposure to 2M methanol + 0.05M sucrose 
for 10,20 and 30 minutes with nomlalised survivals of 47.66 ± 3.7% 46.49 ± 2.9% and 
44.53 ± 2.0% respectively (FDA-PI assessment). After treatment of 2M methanol alone, 
liver cells were able to survive for 10, 20 and 30 minutes with normalised survivals of 
83.26 ± 2.4% 66.33 ± 3.5% and 57.14 ± 3.5% respectively. Although the combination of 
methanol and sucrose showed some adverse effect to liver cells, no significant reduction 
(p > 0.05) in liver cell survivaI was found between 10, 20 and 30 minutes. 
Although the loss in the survival from 2M methanol + 0.05M sucrose treatment 
was higher than 2M methanol treatment, 2M methanol + 0.05M sucrose was applied to 
the cells in subsequent experiments providing comparative results to 2M methanol alone. 
DMSO, MeOH, PG and sucrose cryoprotection of liver cells were compared in 
this study. All cryoprotectants prove to have the same mild toxicity towards liver cells 
since their decreases in percentage survivals were of the same extent when viability 
assessment was done with TB but not in FDA-PI assessment. DMSO is the most 
commonly used cryoprotectant for cell cryopreservation (Lubzens, 1997; Vieira et al., 
2002; Son et al., 2004, Wani et aI., 2004; Eroglu and Bailey, 2005; Pedro et aI., 2005; 
Katkov et aI., 2006), including fish species (Wang et aI., 2003; Mauger et aI., 2006; 
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Wazir, 2006), the results from FDA-PI assessment of CPA toxicity indicated that 1M 
DMSO was more toxic to the cells than 2M methanol. Although methanol is considered 
to be one of the most toxic cryoprotectants (Leung and Jamieson, 1991), it was 
successfully used in tilapia (Harvey, 1983; Rana and McAndrew, 1989), in salmonid 
fishes (Lahnsteiner et al., 1997) and recently in the catfish Pseudoplatystoma corruscans 
(Carolsfeld et aI., 2003). One explanation for the different results could be that in this 
study the viability assessments were carried out with TB and FDA-PI while some studies 
used only TB for initial assessment (Wang et aI., 2003; Mauger et al., 2006; Wazir, 
2006). Moreover, FDA-PI is considered to be more consistent than TB since FDA-PI not 
only assesses the membrane integrity of liver cell but also the enzymic activity of cells, 
may be the reason why TB always resulted in higher survival rate than FDA-PI. Thus, in 
this study, methanol was selected to be the optimum CPA to treat the liver cells according 
to the results from FDA-PI test. 
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CHAPTER 4 CHILLED STORAGE OF LIVER CELLS 
4.1 Introduction 
Cold shock injury has been recognised in a wide range of cell type and tissues 
including mammalian spermatozoa, eggs, embryos, blood cells and micro-organism 
(Morris and Watson, 1984). Many studies (Holt and Noth, 1988; Drobnis et al., 1993; 
Arav et al., 1996; Crowe et aI., 1999) support the theory that lipid phase transition in cell 
membranes is responsible for cold shock injury. Another theory, the thermoelastic stress, 
was proposed by McGrath (1984) in which the reduction of temperature results in 
membranes attempting to thermally contract laterally around an essentially 
incompressible aqueous interior. 
Chilling injury can be classified into two distinct categories (Morris and Watson, 
1984): direct chilling injury or cold shock and indirect chilling injury (Section 1.2.1). 
Cold shock is used to describe phenomena that are dependent on cooling rate and 
expressed quickly upon the reduction in temperature. However, indirect chilling injury is 
independent in the rate of cooling and is usually manifested after an extended exposure 
time at a low temperature (Morris and Watson, 1984). In some cases, it is difficult to 
determine whether the effect depends on direct or indirect chilling injury because chilling 
injury can arise very quickly such as in bovine oocytes (Martino et aI., 1996). However, 
the effects of chilling injury on cell physiology are complex (Morris and Clarke, 1987). 
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This present study sets out to detennine the effect of a combination of bathing 
solutions, storage temperatures and times or just CPAs undergone slow cooling procedure 
alone. The effect of short-term storage at 4°C and 6Co, which may be needed prior to the 
cryopreservation, was studied. Liver cells were stored for up to 48 hours before assessed 
using FDA-PI. The optimal CPAs (methanol and methanol + sucrose) were used to treat 
both fresh and stored liver cells before cryopreservation. The slow cooling process was 
performed to investigate the effect on sensitivity of fresh and stored liver cells to low 
temperature. 
4.2 Results 
Understanding the mechanisms of chilling injury and freezing damage may enable 
the adverse effects to be overcome and allow the development of methods that allow low 
temperature maintenance of living cells, tissues or organs. PBS and medium C were used 
as the bathing solutions in this study to store the liver cells at 4°C and 6°C. Although 
there was no ice formation during the short tenn storage, the loss of cells surviving short 
term storage is probably due to chilling injury since the optimal temperature of the cells 
was 22°C. Combinations of storage temperature, storage times and bathing media were 
investigated with a view to finding the optimum procedure for short term maintenance of 
liver cells. Cell survival was assessed using the vital staining FDA-PI test. TB staining 
was not use to assess the cell viability due to cell aggregation occuring during the period 
of storage. 
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4.2.1 The chilled storage of liver cells 
4.2.1.1 Effect of exposure time and bathing solution on chilling injury in 
zebrafish liver cells 
Liver cell survival following exposure to 4°C for 12, 24 and 48 hours in PBS or 
medium C are shown in Table 4.1. There is some indication that PBS gave a higher 
survival rate than medium C, but it was only statistically significant (p < 0.05) at 24 
hours of the storage. No significant difference (p > 0.05) was found in the survival of 
liver cells after exposure at 4°C for 12 and 48 hours between the different bathing 
solutions. A reduction in survival of cells in PBS was also manifested (p < 0.001) during 
storage from 12-24-48 hour. However, there was a significant fall (p < 0.05) in cell 
survival during 12 to 24 hour of the storage in medium C, but no significant further loss 
(p > 0.05) in survival during 24 to 48 hour. 
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4.2.2 The cryopreservation of liver cells 
As a result from the previous investigation, 2M methanol and 2M methanol + 
sucrose were chosen to be the optimum CPAs, and the best CPA exposure time was 10 
minutes. Liver cells were treated with O.05M sucrose + 2M methanol or 2M methanol 
alone for 10 minutes at 22°C. The slow cooling protocol used in this study was the 
standard procedure to cryopreserve blastomeres of Rainbow Trout (Calvi and Maisse, 
1998). They then chilled in the KRYO 10 controlled rate cooler with a slow (S·C I min) 
cooling rate from a starting temperature of 20 to -7.S·C, followed by a cooling rate of 
OJoC/min until -40°C, and then 2°C/min to -80·C and held for 10 minutes at -80DC 
before plunging into LN2. The cells were held in LN2 for 10 minutes. After freezing, the 
liver cells were thawed in a water bath at 2TC for 10 seconds. Survival rates were 
assessed using TB or FDA-PI. 
4.2.2.1 Effect ofmethanol on the viability of fresh liver cells 
After exposure to 2M MeOH for 10 minutes, liver cells were subdivided into two 
groups. The fIrst group was assessed with TB and FDA-PI, and the second group was 
cryopreserved by the controlled cooler following thawing. The post-thaw survival ofliver 
cells after cryopreservation is shown in Fig. 4.4. The studies revealed that liver cells can 
tolerate a 10 minute exposure to 2M methanol and freeze-thawing with normalised 
survival of76.08 ± 8.2 % and 58.98 ± 5.9 for TB and FDA-PI assessments, respectively. 

------
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reduction was observed between 10 and 20 minutes of CPA exposure. 

Table 4.4 Percentages of viable cells after cryopreservation following methanol + sucrose 

treatment for up to 30 minutes. 

Normalised survival of liver cells after cryopreservation 
following 2M methanol + O.05M sucrose treatment 
Normalised survival (%) 
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80 +---------------~------------~------------------~ 
60 +---------------------------------------~--------~ i. TB !I 
: III. FDA+PI II40 +---r-+-~~--------~~~----------------------~ 
L 
 10 20 30 
Exposure time to CPAs at room temperature (min) 
Fig. 4.5 Effect of cryopreservation on the survival of fresh liver cells fo llowing 2M 
methanol + 0.05M sucrose treatment for 10, 20 and 30 minutes. Liver cells were 
collected from four male fish. They were exposed to 2M methanol + 0.05M sucrose for 
10, 20 or 30 minutes. They were then cryopreserved in a controlled cooler. Thawing was 
carried out, and FDA-PI was used to assess the viability. 
After slow cooling in cryopreservation study, it showed that only 39.96 ± 5.6% 
and 33.48 ± 3.6% (TB and FDA+PI assessments, respectively) survived the cooling 
process following 10 minutes exposure to 2M methanol + O.05M sucrose. However, liver 
cells exposed to 2M methanol for 10 minutes were able to survive the cooling procedure 
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with normalized survival of 76.08 ± 38.2% and 58.98 ± 5.9% for TB and FDA+PI 
assessments, respectively. As a result, only 2M methanol was selected for use in further 
studies of the sensitivity of the stored liver cells. 
4.2.2.3 Cryopreservation of chill-stored liver cells 
Liver cells were stored in PBS or medium e for 12 hours at 4°C or 6°C. They 
were then treated with 2M methanol and cryopreserved followed by viability assessment 
using FDA-PI test. The standard cooling procedure was the same to that applied to the 
fresh cells. After methanol treatment, cells were cooled in the KRYO 10 controlled rate 
cooler with a slow (-SOC / mi.n) cooling rate from a starting temperature of 20°C to -7.5°C 
followed by -0.3°e/min until -40°C, then by -2°C/min and held for 10 minutes at -80°C. 
The cells were fmally plunged into LN2 and held for 10 minutes. After freezing, the liver 
cells were warmed to 26°C for 10 seconds in a water bath to observe survival rates using 
the FDA-PI stain. 
Fig. 4.6 shows the effect of bathing solutions and storage temperatures after 12 
hour exposure and cryopreservation by slow cooling on zebrafish liver cell survival. 
Liver cells were stored at 4°C and 6°C in different bathing solutions, PBS and medium C 
for up to 12 hours. They were treated with 2M methanol for 10 minutes before 
undergoing cryopreservation. The assessments were carried out before the slow cooling 
procedure and after the thawing process. Only FDA-PI was used to assess the cell 
viability because after short-term storage, the liver cells aggregated and it was hard to 
distinguish between viable and non-viable cells using TB staining. 
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After 12 hour storage in PBS or medium C and before cryopreservation, a 
significant drop (p < 0.05) was fOlmd in the survival of liver cells at 6°C, and it was 
highly significant (p < 0.001) at 4°C. No significant difference (p > 0.05, n = 6) was 
found in liver cell survival between the two bathing solutions at 4°C whereas, at 6°C, the 
effect of bathing solutions on liver cell survival was significant (p < 0.05, n = 6). 
In addition, slow cooling resulted in a significant reduction (p < 0.001) in liver 
cell survival for all experiments. Liver cells aggregated following 12 hour storage in PBS 
at 6°C. However, liver cells from 12 hour storage at 4°C can tolerate slow cooling with 
normalised survival 62.72 ± 6.1% and 57.58 ± 5.6% in PBS and medium C, respectively. 
Values are means ± SEM (n=9). Bathing solutions had no significant effect on the 
survival of liver cells while difference (p < 0.05) were observed from the survival 
experienced slow cooling following different storage temperatures. Storage at 6°C 
resulted in lower survival of cryopreserved liver cells than storage at 4°C. 
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Table 4.5 Percentages of viable cells after cryopreservation following 12 hour storage and 2M methanol treatment for 10 minutes. 
Medium after 12 hour storage at 4 DC and cryopreservation Mean 
+ 
control 71.87 73.58 68.18 71.21 
PBS 70.37 73.92 63.43 69.24 
MC 69.213 78.39 76.92 74.841 
After 
Cryo 1 mean 2 mean 3 Mean ! 
PBS 45.45 47.82 42.85 45.3733 46.67 42.86 42.86 44.13 46.15 42.85 33.33 40.7767 
MC 36.36 47.82 42.85 42.3433 39.28 36.36 38.46 38.0333 45.45 41.67 44.~,- 43.85 
Medium after 12 hours storage at 6D C and cryopreservation Mean 
+ 
control 79.45 82 77.1 79.5167 
PBS 67.24 69.23 68.18 68.2167 
MC 67.64 66.67 65.9 66.7367 
After 
Cryo 1 mean 2 mean 3 Mean 
,-----MC 26.92 I 30 I 29.72 28.88 30 I 31.42 I 30.77 30.73 32.33 I 28.57 I 32.5 31.1333 
Liver cells were collected from six male fish. After digestion for 5 minutes, they were equally separated and left in different bathing 
solutions for 12 hours at 4"C or 6"C. They were then cooled in a controlled cooler machine following FDA-PI assessment. After they 
were thawed in 26"C water bath, the liver cells were assessed again by FDA-PI. The survival of the non-treated control was 74.54 ± 
3.2% and 79.52 ± 2.4% for liver cell storages at 4°C and 6°C, respectively. 
I 
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4.3 Discussion 
4.3.1 Liver cell storage 
The results from the present study showed that similar chilling injury levels were 
obtained with PBS and medium C. However, PBS gave a higher survival rate than 
medium C at 4°C for 24 hours (p < 0.05). Moreover, the reduction of the survival in PBS 
was significantly greater than in medium C from 24 to 48 hour storage at 4°C (p < 0.05). 
Storage at 4°C gave higher survivals than 6°C in both PBS and medium C (p < 0.05). 
Conversely, there were no significant different in survivals between both storage 
temperatures after 24 hour storage in medium C (p > 0.05). As a result, storage in PBS at 
4°C for 12 hours was selected to be the best condition for short term storage liver cells. 
4.3.2 The viability of fresh liver cells following slow cooling 
The previous studies showed the survival rates of liver cells were reduced due the 
concentration and exposure time of CP As. In this study, 2M methanol + 0.05M sucrose 
and 2M methanol alone were used to treat liver cells before slow cooling was done. The 
reduction in survival of liver cells undergoing the slow cooling procedure following 
longer exposure to 0.05 sucrose together with 2M MeOH for 30 minutes was significant 
greater (p < 0.05) than 10 and 20 minutes when assessed using FDA-PI assessment, 
which was considered to be more reliable than TB. Liver cells were able to survive the 
slow cooling procedure following 2M methanol + 0.05M sucrose treatment for 10 
minutes with normalised survival of 43.86 ± 4.8%, as determined by the FDA-PI test. 
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However, there were 58.98 ± 5.9% of nonnalised survivals assessed by FDA-PI when 
liver cells were exposed to 2M methanol for 10 minutes and cryopreserved. The 
comparison of cell survival rates after slowed cooling showed that 2M methanol was 
more suitable to treatment for liver cells prior to the cooling procedure than 2M methanol 
+ sucrose. In the study of cryopreservation of primary culture fills cells, half of the cells 
was recovered after -70°C freezing with DMSO (Mauger et al., 2006) 
4.3.3 The viability of stored liver cells undergoing slow cooling 
Since 2M methanol was proved from the earlier studies to be an optimal CPA for 
liver cells, all stored liver cells were treated with 2M methanol for 10 minutes prior to the 
slow cooling procedure. Methanol is the most effective and generally applicable 
cryoprotectant for salmonid semen (Lahnsteiner et al., 1997) and tilapia (Harvey, 1983; 
Rana and McAndrew, 1989). While the liver cells were stored at 4°C and 6°C, the 
survival was reduced due to exposure temperature and time according to the previous 
studies. A significant reduction of the survival after undergoing slow cooling occurred in 
all trials, as occurred with fresh cells. In the study of fin cell cryopreservation, the 
percentage recovery after thawing indicated that 40% to 50% of the cells which 
underwent the cryopreservation procedure were lost, likely because they broke during the 
freezing-thawing-washing (Mauger et al., 2006). Difference in bathing solutions did not 
improve the survival rate after cryopreservation since the liver cells were treated with the 
same CPA method. However, all1iver cells stored at 6°C for 12hr in PBS did not survive 
I 
i 
I 
after the slow cooling process. 
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5.1 Reiteration of Aims 
Successful cryopreservation allows the long term storage of viable cells and 
tissues. However, survival at extremely low temperature is seen in many species of 
plants, microorganisms, insects, and reptiles, and many animals can survive winter by 
using different strategies to tolerate freezing within their tissues. Understanding these 
natural cryoprotection mechanisms can inform cryopreservation protocol design. 
Cryobiology is of increasing importance due to the demand for cryopreserved 
tissues and gametes for use in cryomedicine and conservation. In cryo-conservation, the 
approach is the banking of gametes, embryos, DNA and cells of endanger species. Whilst 
the most valuable resources are gametes and embryos, DNA and somatic cells would 
provide alternative resources when cryo-preservation of gametes and embryos is not 
possible due to either availability or inability to successfully cryopreserve. However, the 
successful cryo-preservation can only be performed in well established central 
laboratories with expertise in cryopreservation. Therefore, there is a need for protocols 
that can be achieved away from the specialist laboratory since collecting sample is 
usually carried out in the field, on board survey vessels and in the aquarium. In this case, 
non-freezing preservation of viable tissue samples at temperature close to O°C with 
capability to generate cell cultures would be appropriate for collection and transport of 
samples to a processing laboratory. The purpose of this study was to establish a protocol 
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for short-term storage and cryopreservation. The combinations of bathing solutions, 
exposure temperatures, and storage times were determined. The study was also intended 
to fmd the optimal cryoprotectant treatment for liver cells. 
The approach used zebrafish (Danio rerio) as the model system and liver cells as 
a model cell type. Fish were anaesthetised with a lethal dose of tricane prior to 
decapitation and dissection of liver tissue for storage and cryopreservation. To achieve 
this aim, three main areas were investigated with liver cells of zebrafish: (1) the toxicity 
of a range of cryoprotectants using vital staining assessments, (2) determination of initial, 
pre-cryopreservation, storage temperature, and (3) cooling regime effects. 
5.2 Review of the Main Findings 
5.2.1 Cryoprotectant toxicity 
The liver cells were collected from zebrafish anaesthetised with tricane and 
decapitated. The liver cells were washed and digested before being treated with different 
concentrations of cryoprotectants. The first study investigated the cryoprotectant toxicity 
of the penetrating CPAs, MeOH, DMSO, and PG. These results indicated that for the 
liver cells, treatment with 2M Methanol gave a higher viability rate compared to 3M and 
4M methanol and 1M PG and DMSO for all ranges of times as determined by the vital 
stain tests used, TB and FDA-PI. Moreover, 2M methanol treatment for 10 minutes was 
the optimum condition to treat the cells. The second study looked at the non-penetrating 
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cryoprotectant, sucrose, to find the optimum range of concentrations to be used in 
combination with methanol. The viability assessments were also done by TB and FDA­
PI. Sucrose of 0.05M was chosen to treat the liver cells together with 2M methanol. The 
results showed that sucrose with methanol gave lower survival rate then methanol alone. 
Although 2M methanol with 0.05M sucrose was more toxic to the cells more than 2M 
methanol, it was used to treat the cell in further study on cell cryopreservation to give 
comparative results to 2M methanol alone. 
5.2.2 Chilled storage of liver cells 
This investigation was attempted to determine whether initial storage of cells at 
4°C and 6°C can be used, prior to cryopreservation for long term storage in LN2. Two 
bathing solutions, medium C and PBS were selected for a range of storage times (12 hr to 
48 hr period) at 4°C or 6°C, and viability assessment after 12 hr to 48 hr storage was 
done to identify the optimum condition. Cell survival was assessed using the vital 
staining FDA-PI test. TB staining was not use to assess the cell viability due to the cell 
aggregation during period of the storage. After short-term storage without ice formation, 
the loss of the cell survivals was due to chilling injury because the optimal temperature of 
the cells was 22°C. The results indicated that similar chilling injury levels were obtained 
with PBS and medium C. However, the survival in PBS was significantly higher (p < 
0.05) than that in medium C after 24 hour storage at 4°C (Fig. 4.1). The results from two 
different storage temperature, used to store liver cells for 12, 24 and 48 hours, indicated 
that liver cells survived significantly better (p < 0.05) at 4°C than at 6°C in both bathing 
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solutions (Fig. 4.2 and Fig. 4.3). However, similar survivals were obtained from 24 hour 
storage in medium C at 4°C and 6°C. The reduction of survival was also due to the 
increase in exposure time. Therefore, the further studies in stored liver cells were limited 
to exposure for 12 hours. 
5.2.3 Cryopreservation of liver cells 
Controlled slow cooling had been used to examine the role of cryoprotective 
agents during freezing. The objectives of this study are to refine and select an optimum 
protocol for controlled slow cooling assessed by post thaw viability. Fresh and stored 
liver cells of zebrafish were cooled to various subzero holding temperatures and cooled to 
-196°C before thawing. The optimum slow cooling was based on existing LIRANS 
procedure to cryopreserve zebrafish blastomeres. Fresh liver cells were suspended in 2M 
methanol or 2M methanol + 0.05M for various exposure times before freezing. Initial 
results indicate fresh liver cells of 10 minutes treatment in 2M methanol gave the best 
survival when compared to methanol + sucrose and other ranges of treating times (Fig 4.4 
and 4.5). The highest survival rate in the present study was approximately 76.08 ± 8.2 % 
and 58.98 ± 5.9% for TB and FDA-PI assessments, respectively (Fig. 4.4). Values are 
means ± SEM. Thus, only 10 minute treatment of 2M methanol was used to treat stored 
liver cells for further studies in cryopreservation of stored liver cells. Before the 
treatment, liver cells were stored at 4°C or 6°C for up to 12 hours. Medium C and PBS 
were used as bathing solutions to store the cells. After 12 hours of storage, 43.43 ± 4.2% 
and 41.41 ± 4.0% of liver cells were able to survive slow cooling following exposure to 
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4°C in medium C and PBS, respectively (Fig. 4.6). Values are means ± SEM, and the 
assessment was done by using the FDA-PI test due to cell aggregation during short-tenn 
storage. Less than 5% of liver cells could survive slow cooling following 12 hour storage 
at 6°C in PBS. However, liver cells were able to survive the exposure to 6°C in medium 
C for up to 12 hours with 31.13 ± 1.8% survival. 
5.3 Conclusion 
TB exclusion and FDA-PI are essential indicators addressing the quality of the 
recovered cells to ensure that the functionality of the recovered cells is preserved. 
Depending on the indicators used in the study to assess quality of liver cells recovered 
after thawing, different results of the damage induced by procedures prior to and 
subsequent to cryopreservation were obtained. TB is the most commonly used dye 
exclusion assay providing infonnation on membrane integrity because it reflects plasma 
membrane ability to exclude the dye. FDA-PI provides some further information on 
metabolic activities (esterase activity, which cannot be found in dead cells), and it 
appears that FDA-PI is a better indicator of the cell quality than TB. 
5.3.1 Optimum protocol for storage of zebrafish liver cells 
Comparison of liver cells in different bathing solutions revealed that both PBS 
and medium C could support their in vitro storage (Fig 4.1). In the chilled storage study, 
liver cells were stored at 4°C and 6°C, and results showed that 4°C was the optimum 
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temperature. Statistical analysis indicated that the survival of store liver cells was 
significantly greater at 4°C than 6°C (p < 0.05). However, there was no significant 
different in the survival ofliver cells, stored in medium C for 24 hours between these two 
temperatures (p > 0.05). Although it is unusual to find different effects across a narrow 
temperature range, temperature sensitive cellular mechanisms may have practical 
implications for cell survival. These include the effect on active ion transport and cell 
volume regulation in consequence of the storage media for cells held at low temperature. 
Depending on the exposure temperature, membrane viscosity and phase separation may 
occur, which have direct effect on membrane function and determine the long-term 
survival. Change in enzymic profiles may also occur and reduce survival at lower 
temperatures. Such physiological changes may possibly explain the lower proportion of 
viable cells at the lower temperature. 
5.3.2 Potential protocol for future cryopreservation ofzebra fish liver cells 
The CP As should be diluted to the desired concentration in PBS prior to adding 
them to the cell suspension. This minimises the potentially deleterious effects of chemical 
reactions such as reducing potential toxic effects. DMSO, MeOH, PG and sucrose 
cryoprotection of liver cells were compared in this study. DMSO is the most commonly 
used cryoprotectant for cultured cells, including fish (Wolf and Quimby, 1969). All 
cryoprotectants proved to have some degree of toxicity towards liver cells. The survivals 
of fresh liver cells exposed to 1M DMSO, 2M MeOH, 1M PG and O.05M sucrose for up 
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to 10 minutes were similar when assessed with TB. This study showed that these four 
cryoprotectant concentrations had almost the same toxicity to liver cell. Except when the 
survivals were assessed by FDA-PI, MeOH proved to be less toxic and yield high 
survivals, comparing to the other three CPAs. The optimum concentration and exposure 
time of the CPA treatment proved from the studies with the liver cells of zebrafish were 
the exposure to 2M methanol for 10 minutes. The sensitivity of the cells was raised with 
increasing concentrations of the CPA. 
The percentage recovery of liver cells after thawing indicated that approximately 
40% to 60% of the stored cells, which underwent the cryopreservation procedure were 
lost, likely because they broke during the freezing-thawing -washing procedure. The 
viability and estimate of recovery were determined both before and after freezing the 
cells. A comparison of the counts prior to and after freezing indicated that the success of 
the fresh liver cell preservation procedure could be more than 60% and 40% as assessed 
by TB and FDA-PI, respectively. With the optimum storage temperature and time, more 
than 40% of the stored cells were able to recover after the slow cooling procedure. 
5.3.3 Assessment of cryopreserved cell quality 
Depending on the indicators used in the study to assess quality of liver cells 
recovered after CP A treatments, different damages induced by CPA toxicity to the cells 
were shown. The most commonly used IB exclusion assay gave information on 
membrane integrity. FDA-PI assessed membrane integrity and enzymatic activity inside 
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the cells. Recovery percentage of the cell population was calculated as the ratio of the 
viable cell number after thawing to the number of viable cells before CPA treatment, 
short-term storage or cryopreservation x 100. However quality of the cells recovered after 
thawing and washing of the CPA was assessed only with FDA-PI in this study since there 
was a difficulty in counting the cells on haemocytometer using TB exclusion essay 
because of the cell aggregation during period of the storage. Although FDA-PI can give 
more consistent results than TB, there is not yet sufficient evidence to claim that all cells 
identified as viable by the FDA-PI test are of good quality and able to generate cell 
cultures. The purpose of cell cryopreservation in this study was focused on subsequent 
use in establishing cell cultures. Alternative tests for cell viability would more accurately 
define the viability ofthe cells. Metabolic activities of the cells could be assessed by ATP 
levels or enzymic activity. Phase contrast or differential interference contrast image could 
be used to assess the proportion of live and dead cells. Moreover, assessments in the 
properties of the membrane protein and adhesion ability of the thawed cells would 
provide more reliable consequence for the quality of the cells. 
• 
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5.4 Future work 
Three areas of future study are identified that would be valuable in optimising the 
use of tissue explants for cryobanking. 
• 	 Optimisation of cooling protocol- As the cooling regime in the present study was 
based on existing LIRANS procedure for cryopreservation of zebrafish blastomeres, 
a full range of slow cooling methods and final holding temperatures should be 
explored to determine optimum protocol. Successful procedures would then be 
available for the collection and preservation of viable tissue explants from fish, for 
subsequent use in establishing cell cultures for cryobanking. 
• 	 Development of culturing protocols for confirmation of viability and maintenance of 
(i) chill-stored explants, and (ii) cryopreserved chill-stored explants- The capability 
to generate cell cultures should be investigated. Initially protocol reported by other 
works would be used to optimise culture conditions. The culture characteristic of 
untreated and non-cryopreserved material would be used to compare to the culturing 
of preserved materials. Further work on cell culture would aim to allow cryobanking 
of fish somatic cells from liver explants with an assessed and optimal success rate. 
• 	 Investigation of other sources of explants material for use in cryo-banking- The 
application of the cryopreservation procedure would be tested on several other post­
mortem materials from zebrafish such as fin, caudal peduncle, gill, and heart. The 
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amenability of explants from different tissue types to tolerate the short-term storage 
and cryopreservation would be assessed. The study would provide protocols for 
cryobanking to enable successful cryopreservation of cells of different origins. 
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